BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2436328)

  • 1. An enzyme immunoassay (ELISA) for the quantitation of human factor VII.
    Boyer C; Wolf M; Rothschild C; Migaud M; Amiral J; Mannucci PM; Meyer D; Larrieu MJ
    Thromb Haemost; 1986 Dec; 56(3):250-5. PubMed ID: 2436328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assay of factor VII antigen by enzyme-linked immunosorbent assay (ELISA)].
    Takamiya O
    Rinsho Byori; 1991 Apr; 39(4):437-41. PubMed ID: 2051627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ELISA method for the determination of factor VII antigen].
    Jorquera JI; Aznar JA; Monteagudo J; Montoro JM; Casaña P; Pascual I; Bañuls E; Curats R; Llopis F
    Sangre (Barc); 1989 Dec; 34(6):514-7. PubMed ID: 2629128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new method for the estimation of protein C by ELISA.
    Boyer C; Rothschild C; Wolf M; Amiral J; Meyer D; Larrieu MJ
    Thromb Res; 1984 Dec; 36(6):579-89. PubMed ID: 6084875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated factor IX-antithrombin III complexes in human blood: quantification by an enzyme-linked differential antibody immunoassay and determination of the in vivo half-life.
    Takahashi I; Kato K; Sugiura I; Takamatsu J; Kamiya T; Saito H
    J Lab Clin Med; 1991 Oct; 118(4):317-25. PubMed ID: 1940573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
    Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
    Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of factor VII antigen in factor VII congenital deficiencies with a new ELISA assay.
    Tirindelli MC; Mariani G; Mazzucconi MG; Iacopino G; Carbonaro M; Ghirardini A; Motta M; Mandelli F
    Am J Hematol; 1987 Dec; 26(4):313-21. PubMed ID: 2961255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoradiometric assays for human coagulation factor VII using polyclonal antibodies against the Ca(II)-dependent and Ca(II)-independent conformation.
    Bom VJ; van Tilburg NH; Krommenhoek-van Es C; Bertina RM
    Thromb Haemost; 1986 Dec; 56(3):343-8. PubMed ID: 2436334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sensitive ELISA for von Willebrand factor (vWf:Ag).
    Ingerslev J
    Scand J Clin Lab Invest; 1987 Apr; 47(2):143-9. PubMed ID: 3107116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
    Welfringer F; d'Athis P; Scherrmann JM; Hervé F
    J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal anti-human factor VII antibodies. Detection in plasma of a second protein antigenically and genetically related to factor VII.
    Broze GJ; Hickman S; Miletich JP
    J Clin Invest; 1985 Sep; 76(3):937-46. PubMed ID: 2995451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
    Panush RS; Somberg LB; Katz P; Longley S
    Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The usefulness of ELISA test for early serological detection of Trichinella spp. infection in pigs].
    Bień J
    Wiad Parazytol; 2007; 53(2):149-51. PubMed ID: 17912813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma thromboplastin antecedent (PTA, factor XI): a specific and sensitive radioimmunoassay.
    Saito H; Goldsmith GH
    Blood; 1977 Sep; 50(3):377-85. PubMed ID: 884316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of methods for the measurement of activated factor VII.
    Kitchen S; Malia RG; Preston FE
    Thromb Haemost; 1992 Sep; 68(3):301-5. PubMed ID: 1440496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital factor VII deficiency. Clinical and laboratory characteristics of a newly discovered kindred.
    Kernoff LM; Hughes J; Denson KW
    Clin Lab Haematol; 1982; 4(2):109-15. PubMed ID: 7116793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study.
    Miller GJ; Stirling Y; Esnouf MP; Heinrich J; van de Loo J; Kienast J; Wu KK; Morrissey JH; Meade TW; Martin JC
    Thromb Haemost; 1994 Jan; 71(1):38-48. PubMed ID: 8165645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factor VII and protein-C markers are no prognostic indicators in acute coronary heart disease].
    Friesewinkel O; Marbet GA; Ritz R
    Schweiz Med Wochenschr; 1993 Jan; 123(3):82-4. PubMed ID: 8426952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on immunological assay of vitamin K dependent factors. I. Measurement of factor VII antigen by radioimmunoassay.
    Mikami S; Tuddenham EG
    Br J Haematol; 1986 Jan; 62(1):171-81. PubMed ID: 3484635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ELISA method using microplates developed with commercial antisera for measuring von Willebrand factor antigen].
    Jorquera JI; Montoro JM; Aznar JA; Perales MA; Lerma MA; Curats R; Bañuls E; Casaña P
    Sangre (Barc); 1989 Apr; 34(2):147-50. PubMed ID: 2787936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.